Gottfried Schenker
Sign in to saveSwiss businessman (1842-1901)
Recent publications · Crossref
5 total works indexed
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
· 2016 · cited 8,647x
- Accurate whole human genome sequencing using reversible terminator chemistry
· 2008 · cited 3,021x
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
· 2021 · cited 2,725x
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
· 2020 · cited 2,672x
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
· 2012 · cited 2,263x
via Crossref · CC0
Wikidata facts
- Instance of
- human
- Given name
- Gottfried
- Gender
- male
- Citizenship
- Switzerland
- Place of birth
- Däniken
- Place of death
- Vienna
- Occupation
- entrepreneur
- Languages spoken
- German
- Religion
- Catholicism
- Notable work
- Schenker AG
- Image
- Gottfried Schenker.jpg
Show 5 more facts
- Commons category
- Gottfried Schenker
- date of birth
- 1842-02-14
- date of death
- 1901-11-26
- Commons gallery
- Gottfried Schenker
- municipal affiliation of a Swiss national
- Däniken
via Wikidata · CC0